121 related articles for article (PubMed ID: 1309059)
1. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
[TBL] [Abstract][Full Text] [Related]
2. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
Kruithof EK; Schleuning WD
Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
[TBL] [Abstract][Full Text] [Related]
4. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression.
Krätzschmar J; Haendler B; Langer G; Boidol W; Bringmann P; Alagon A; Donner P; Schleuning WD
Gene; 1991 Sep; 105(2):229-37. PubMed ID: 1937019
[TBL] [Abstract][Full Text] [Related]
5. Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration.
Witt W; Maass B; Baldus B; Hildebrand M; Donner P; Schleuning WD
Circulation; 1994 Jul; 90(1):421-6. PubMed ID: 8026028
[TBL] [Abstract][Full Text] [Related]
6. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
[TBL] [Abstract][Full Text] [Related]
7. Production of vampire bat plasminogen activator DSPA alpha 1 in CHO and insect cells.
Petri T; Langer G; Bringmann P; Cashion L; Shallow S; Schleuning WD; Donner P
J Biotechnol; 1995 Feb; 39(1):75-83. PubMed ID: 7766013
[TBL] [Abstract][Full Text] [Related]
8. P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.
Dong N; Da Cunha V; Citkowicz A; Wu F; Vincelette J; Larsen B; Wang YX; Ruan C; Dole WP; Morser J; Wu Q; Pan J
Thromb Haemost; 2004 Nov; 92(5):956-65. PubMed ID: 15543321
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats.
Witt W; Baldus B; Bringmann P; Cashion L; Donner P; Schleuning WD
Blood; 1992 Mar; 79(5):1213-7. PubMed ID: 1536947
[TBL] [Abstract][Full Text] [Related]
10. High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells.
Krätzschmar J; Haendler B; Bringmann P; Dinter H; Hess H; Donner P; Schleuning WD
Gene; 1992 Jul; 116(2):281-4. PubMed ID: 1634121
[TBL] [Abstract][Full Text] [Related]
11. Vampire bat plasminogen activator DSPA-alpha-1 (desmoteplase): a thrombolytic drug optimized by natural selection.
Schleuning WD
Haemostasis; 2001; 31(3-6):118-22. PubMed ID: 11910176
[TBL] [Abstract][Full Text] [Related]
12. Vampire bat salivary plasminogen activator.
Gardell SJ; Friedman PA
Methods Enzymol; 1993; 223():233-49. PubMed ID: 8271956
[No Abstract] [Full Text] [Related]
13. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
[TBL] [Abstract][Full Text] [Related]
14. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
16. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
Toschi L; Bringmann P; Petri T; Donner P; Schleuning WD
Eur J Biochem; 1998 Feb; 252(1):108-12. PubMed ID: 9523718
[TBL] [Abstract][Full Text] [Related]
17. O-linked L-fucose is present in Desmodus rotundus salivary plasminogen activator.
Gohlke M; Baude G; Nuck R; Grunow D; Kannicht C; Bringmann P; Donner P; Reutter W
J Biol Chem; 1996 Mar; 271(13):7381-6. PubMed ID: 8631761
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator.
Gardell SJ; Duong LT; Diehl RE; York JD; Hare TR; Register RB; Jacobs JW; Dixon RA; Friedman PA
J Biol Chem; 1989 Oct; 264(30):17947-52. PubMed ID: 2509450
[TBL] [Abstract][Full Text] [Related]
19. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
[TBL] [Abstract][Full Text] [Related]
20. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Hare TR; Gardell SJ
Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
